Clinical trials
Phase 1 Smoldering Multiple Myeloma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2012 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 1 |
| 2020 | 1 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 4 |
| Active, not recruiting | 3 |
| Recruiting | 1 |
| Terminated | 1 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Janssen Research & Development, LLC | 2 |
| M.D. Anderson Cancer Center | 2 |
| Benovus Bio, Inc. | 1 |
| Case Comprehensive Cancer Center | 1 |
| City of Hope Medical Center | 1 |
| Massachusetts General Hospital | 1 |
| Mayo Clinic | 1 |
| OncoPep, Inc. | 1 |
| Yale University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Smoldering Multiple Myeloma | 11 |
| Multiple Myeloma | 4 |
| Neoplasms, Plasma Cell | 3 |
| Immunoglobulin Light-chain Amyloidosis | 1 |
| Leukemia, Myeloid, Acute | 1 |
| Monoclonal Gammopathy of Undetermined Significance | 1 |
| Myelodysplastic Syndromes | 1 |
| Paraproteinemias | 1 |
Trials
Showing 76 to 11 of 11. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.